|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Assay of matrix metalloproteinases types 1,2,3 and 9 in breast cancer显示文摘 | Remacle AG Noel A Duggan C | | 0，，06： | 1 |
| 2 | O-glycosylation regulates autolysis of cellular membrane type-1 matrix metalloproteinase(MT1-MMP)显示文摘 | Remacle AG Chekanov AV Golubkov VS | 2006 | J Biol Chem2006，281，16： | 1 |
| 3 | Assay of matrix metalloproteinases types 1,2,3 and 9 in breast cancer显示文摘 | Remacle AG Noel A Duggan C | 1998 | Br J Cancer1998，77，6： | 1 |
| 4 | Non-destructive and selective imaging of the functionally active,pro-invasive membrane type-1 matrix metalloproteinase(MT1-MMP)enzyme in cancer cells显示文摘 | Remacle AG Shiryaev SA Golubkov VS | 2013 | J Biol Chem2013，288，20： | 1 |
| 5 | Assay of matrix metalloproteinase types 1,2,3 and 9 in breast cancer 显示文摘 | Noel A Dugganc | 1998 | Br J Cancer1998，77，6： | 1 |
| 6 | Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ ERK signaling in cancer cells显示文摘 | Sounni NE Rozanov DV Remacle AG | 2010 | Int J Cancer2010，126，5： | 1 |
| 7 | Matrix met allo- pt, oteinase 26 proteolysis of the NH2 - terminal domain of the es- trogen receptor beta correlates with the survival of breast cancer patients显示文摘 | Savinov AY Remacle AG Golubkov VS | 2006 | Cancer Res2006，66，： | 1 |
| 8 | Furin regulates the intracellular activation and the uptake rate of cell surfaxe-associated MT1 -MMP 显示文摘 | Remacle AG Rozanov DV Fugere M | 2006 | Oncogene2006，25，41： | 1 |
| 9 | Assay of matrix metalloproteinases types 1,2,3 and 9 in breast cancer显示文摘 | Remacle AG Noel A Duggan C | 1998 | Bri J Can1998，77，6： | 1 |
| 10 | Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer 显示文摘 | Remacle AG Noel A Duggan C | 1998 | Br J Cancer1998，77，6： | 1 |
| 11 | Assay of matrix matalloproteinases types 1,2,3 and 9 in breast cancer显示文摘 | Remacle AG Noel A Duggan C | 1998 | Br J Cancer1998，77，： | 1 |
| 12 | Matrix metallopmteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor 13 correlates with the survival of breast cancer patients显示文摘 | Savinov AY Remacle AG Gohbkov VS | 2006 | Cancer Res2006，66，5： | 1 |
| 13 | Selective and potent furin inhibitors protect cells from anthrax without significant toxicity显示文摘 | Remacle AG Gawlik K Golubkov VS | 2010 | Int J Biochem Cell Biol2010，42，6： | 1 |
| 14 | Epigenetic control of the invasion promoting MTA1-MMP/MMP-2/TIMP-2 axis in cancer cells显示文摘 | Chernov AV Sounni NE Remacle AG | 2009 | Biol Chem2009，284，12： | 1 |
| 15 | Novel MT1-MMP small molecule inhibitors based on insights into hemopexin domain function in tumor growth 显示文摘 | Remacle AG Golubkov VS Shiryaev SA | 2012 | Cancer Res2012，72，9： | 1 |
| 16 | Assay of matrix matalloproteinases types1,2,3 and9 in breast cancer显示文摘 | Remacle AG Noel A Duggan C | 1998 | BrJ Cancer1998，77，： | 1 |
| 17 | Tumor cell surface-associated binding site for the Mr 72,000 type Ⅳ collagenase显示文摘 | Emond HP Remacle AG Noeel AC | 1992 | Cancer Res1992，52，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员